Diseases | Free Full-Text | Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis
Β-Thalassemias | NEJM
Quality of life in patients with β‐thalassemia: A prospective study of transfusion‐dependent and non‐transfusion‐dependent patients in Greece, Italy, Lebanon, and Thailand - Cappellini - 2019 - American Journal of Hematology - Wiley
IJMS | Free Full-Text | Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management
Β-Thalassemias | NEJM
Full article: Revisiting beta thalassemia intermedia: past, present, and future prospects
Significance of genetic modifiers of hemoglobinopathies leading towards precision medicine | Scientific Reports
Current status of beta‐thalassemia and its treatment strategies - Ali - 2021 - Molecular Genetics & Genomic Medicine - Wiley Online Library
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
Thalassaemia - The Lancet
Advances in genome editing: the technology of choice for precise and efficient β-thalassemia treatment | Gene Therapy
Antioxidants as Complementary Medication in Thalassemia | IntechOpen
Safety and efficacy of thalidomide in patients with transfusion-dependent β- thalassemia: a randomized clinical trial | Signal Transduction and Targeted Therapy
Novel genetic therapeutic approaches for modulating the severity of β‑ thalassemia (Review)
Gene Therapy For Beta-Thalassemia: Updated Perspectives | TACG
Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron Chelation | SpringerLink
Cureus | Thalassemia: A Review of the Challenges to the Families and Caregivers
New treatment strategies for β-thalassemia | Encyclopedia MDPI
Pathophysiology and treatment of patients with... | F1000Research
β-Thalassemia | Genetics in Medicine
Biomolecules | Free Full-Text | Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β–Thalassemia
Tricuspid-valve regurgitant jet velocity as a risk factor for death in β- thalassemia | Haematologica
Frontiers | The Future of Gene Therapy for Transfusion-Dependent Beta- Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells
Replacing the suppressed hormone: toward a better treatment for iron overload in β-thalassemia major? | Haematologica
Guidelines for the Management of Transfusion-Dependent Thalassaemia (4th Edition - Version 2.0) by Thalassaemia International Federation (TIF) - Issuu
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica